Overcoming drug resistance to receptor tyrosine kinase inhibitors: Learning from lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overcoming drug resistance to receptor tyrosine kinase inhibitors: Learning from lung cancer

Published:2016-05 Issue: Volume:161 Page:97-110
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Kuwano Michihiko,Sonoda Kahori,Murakami Yuichi,Watari Kosuke,Ono Mayumi

Funder

JSPS KAKENHI

by Life Science Foundation of Japan

St. Mary's Institute of Health Sciences

Fukuoka Foundation for Sound Health

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference145 articles.

1. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors;Akbay;Cancer Discov,2013

2. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs;Akiyama;Somat Cell Mol Genet,1985

3. FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor;Azuma;Oncotarget,2014

4. Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer;Bai;J Clin Oncol,2012

5. Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor adenocarcinomas with acquired resistance to kinase inhibitors;Balak;Clin Cancer Res,2006

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolation and Characterization of a Triterpenoid Compound from Sodhita <i>Semecarpus anacardium</i> L. Drupe Ethanolic Extract and its Anticancer Potential <i>In Vitro</i>;Toxicology International;2024-04-08

2. Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer;International Journal of Pharmaceutics;2024-01

3. An Updated Overview on the Synthesis and Anticancer Evaluation of Quinazoline Derivatives;ChemistrySelect;2023-08-10

4. Structure-based modification of ortho-amidophenylaminopyrimidines as a novel mutant EGFR inhibitor against resistant non-small cell lung cancer;Journal of Molecular Structure;2023-02

5. Epidermal growth factor receptor in asthma: A promising therapeutic target?;Respiratory Medicine;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3